January 11, 2012
The Food and Drug Administration reports it has received applications from drugmakers who wish to produce generic versions of the HIV drugs Isentress (Merck & Co.) and Epivir (GlaxoSmithKline). Isentress was approved for use in adult patients in 2007; in December, FDA expanded its label, allowing the drug to be used in children and adolescents. FDA declined to disclose the names of the generic drug applicants.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.